COVIRNA is a patient-centred Innovation Action aiming to generate a diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications.
A joined-up EU wide approach to protecting our population.
Keep in touch
Sign up to our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
Identifying those at most risk from COVID-19
The overall goal of the COVIRNA project is to generate a diagnostic test based on cardiovascular RNA biomarkers highly predictive of the clinical outcomes of COVID-19 patients and to enable its rapid market uptake with the aim to improve individualised surveillance, care and follow-up of these patients in the context of the current pandemic.Find out more about the project
How we will do it
Our work packages are evolving, but include consideration and development of:
Existing & past
The LIH, through the Cardiovascular Research Unit of the Department of Population Health (DoPH), led by Dr Yvan Devaux, will be the Coordinator of “COVIRNA”. The consortium of organisations delivering COVIRNA includes:
News & Events
The COVIRNA Project Coordinator, Dr Yvan Devaux, discusses the project on Radio ARA
On Thursday, 7 October 2021, from 18:30 to 20:00 CEST, Dr Yvan Devaux, the COVIRNA project coordinator, was a guest speaker at Happy Hour, a show hosted by Wendy Winn on Radio ARA. Dr Devaux spoke about the COVIRNA project and cardiovascular disease management. Dr Devaux started by providing con…
COVIRNA session at the EHMA 2021 Annual Conference highlights the role of predictive models in improving patient outcomes
On Wednesday, 15 September from 13:30-14:45 CEST, the COVIRNA project hosted a session at the EHMA 2021 Annual Conference titled Towards personalised medicine – an innovative diagnostic tool to identify cardiovascular complications in COVID-19 patients. The session examined the benefits of person…
Interview with the COVIRNA Project Coordinator, Yvan Devaux
To learn more about the COVIRNA project, we spoke to Dr Yvan Devaux, project coordinator of COVIRNA and head of the Cardiovascular Research Unit at the Luxembourg Institute of Health. Dr Devaux has a background in biological sciences, with over 18 years of experience in cardiovascular disease res…